Search Page

1

Cite

Share

Pupillometry in healthy volunteers as a biomarker of tramadol efficacy.

Matouskova O, Slanar O, Chytil L, Perlik F. Matouskova O, et al. J Clin Pharm Ther. 2011 Aug;36(4):513-7. doi: 10.1111/j.1365-2710.2010.01203.x. Epub 2010 Aug 24. J Clin Pharm Ther. 2011. PMID: 21729116 Clinical Trial.

Cite

Share

2

Cite

Share

Impact of MDR1 genetic polymorphisms on postoperative piritramide analgesia.

Matouskova O, Slanar O, Adamkova J, Pafko P, Perlik F, Adamek S. Matouskova O, et al. Bratisl Lek Listy. 2013;114(3):133-5. doi: 10.4149/bll_2013_029. Bratisl Lek Listy. 2013. PMID: 23406179

Cite

Share

3

Cite

Share

Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.

Slanar O, Dupal P, Matouskova O, Vondrackova H, Pafko P, Perlik F. Slanar O, et al. Among authors: matouskova o. Bratisl Lek Listy. 2012;113(3):152-5. doi: 10.4149/bll_2012_036. Bratisl Lek Listy. 2012. PMID: 22428763

Cite

Share

4

Cite

Share

Enatiomeric determination of tramadol and O-desmethyltramadol in human urine by gas chromatography-mass spectrometry.

Chytil L, Stícha M, Matousková O, Perlík F, Slanar O. Chytil L, et al. Among authors: matouskova o. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jul 1;877(20-21):1937-42. doi: 10.1016/j.jchromb.2009.04.042. Epub 2009 May 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19482526

Cite

Share

5

Cite

Share

Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection.

Chytil L, Matousková O, Cerná O, Pokorná P, Vobruba V, Perlík F, Slanar O. Chytil L, et al. Among authors: matouskova o. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 1;878(3-4):481-6. doi: 10.1016/j.jchromb.2009.12.005. Epub 2009 Dec 16. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 20018572 Clinical Trial.

Cite

Share

6

Cite

Share

Nabumetone and 6-MNA Pharmacokinetics, Assessment of Intrasubject Variability and Gender Effect.

Světlík S, Štícha M, Matoušková O, Nespěšná L, Sklenář Z, Bartůněk A, Perlík F, Slanař O. Světlík S, et al. Among authors: matouskova o. Am J Ther. 2016 Nov/Dec;23(6):e1498-e1503. doi: 10.1097/MJT.0000000000000158. Am J Ther. 2016. PMID: 25393072 Clinical Trial.

Cite

Share

7

Cite

Share

Pharmacogenetics and immunosuppressive drugs.

Hronová K, Šíma M, Světlík S, Matoušková O, Slanař O. Hronová K, et al. Among authors: matouskova o. Expert Rev Clin Pharmacol. 2014 Nov;7(6):821-35. doi: 10.1586/17512433.2014.966811. Epub 2014 Oct 10. Expert Rev Clin Pharmacol. 2014. PMID: 25301406 Review.

Cite

Share

8

Cite

Share

[Infrared pupilometry as a biomarker of drug effects].

Matousková O, Slanar O, Chytil L, Perlík F. Matousková O, et al. Cas Lek Cesk. 2010;149(2):66-8. Cas Lek Cesk. 2010. PMID: 20662468 Czech.

Cite

Share

9

Cite

Share

Pharmacogenetics of chronic pain and its treatment.

Světlík S, Hronová K, Bakhouche H, Matoušková O, Slanař O. Světlík S, et al. Among authors: matouskova o. Mediators Inflamm. 2013;2013:864319. doi: 10.1155/2013/864319. Epub 2013 May 20. Mediators Inflamm. 2013. PMID: 23766564 Free PMC article. Review.

Cite

Share

10

Cite

Share

Genetic polymorphisms of CYP2C8 in the Czech Republic.

Pechandova K, Buzkova H, Matouskova O, Perlik F, Slanar O. Pechandova K, et al. Among authors: matouskova o. Genet Test Mol Biomarkers. 2012 Jul;16(7):812-6. doi: 10.1089/gtmb.2011.0275. Epub 2012 Feb 7. Genet Test Mol Biomarkers. 2012. PMID: 22313047 Free PMC article. Clinical Trial.

Cite

Share